Extendicare Announces Voting Results From the 2016 Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Extendicare Announces Voting Results From the 2016 Annual and Special Meeting of Shareholders

MARKHAM, ON --(Marketwired - May 27, 2016) - Extendicare Inc. ("Extendicare" or the "Company") ( TSX : EXE ) today announced the results of matters voted on at its annual and special shareholders' meeting held on May 26, 2016 (the "Meeting"), which included the election as directors of the Company, all of the nominees listed in its management information and proxy circular dated April 8, 2016 (the "Information Circular"). The voting results for each of the matters presented at the Meeting are presented below.

The total number of common shares represented by shareholders present in person or by proxy at the meeting was 39,143,562, representing 44.40% of the Company's outstanding common shares.

1. Election of Directors On a vote by a show of hands, the election of the following nine nominees as directors of the Company to hold office until the next annual meeting of the Company, or until their respective successors are elected or appointed, was approved. Proxies were received on this matter as follows:

                 
Nominee   Votes For   %   Votes Withheld   %
Benjamin J. Hutzel   35,665,728   96.66   1,231,594   3.34
Margery O. Cunningham   36,391,088   98.63   506,234   1.37
Sandra L. Hanington   36,490,370   98.90   406,952   1.10
Alan R. Hibben   36,467,675   98.84   429,647   1.16
Donna E. Kingelin   36,588,393   99.16   308,929   0.84
Timothy L. Lukenda   36,618,264   99.24   279,058   0.76
Gail Paech   36,580,818   99.14   316,504   0.86
Alan D. Torrie   35,945,948   97.42   951,374   2.58
Frederic A. Waks   36,498,059   98.92   399,263   1.08
                 

2. Appointment of Auditors On a vote by a show of hands, the appointment of KPMG LLP as the auditors of the Company until the next annual meeting of the Company to be held in the year 2017 was approved. Proxies were received on this matter as follows:

             
Votes For   %   Votes Withheld   %
37,056,425   94.96   1,967,079   5.04
             

3. Long Term Incentive Plan On a vote conducted by ballot, the ordinary resolution to confirm the Company's Long Term Incentive Plan was approved. The results of the vote were as follows:

             
Votes For   %   Votes Against   %
34,995,692   94.85   1,901,631   5.15
             

4. Approach to Executive Compensation   On a vote conducted by ballot, a non-binding advisory resolution to accept the Company's approach to executive compensation disclosed in the Company's Information Circular was approved. The results of the vote were as follows:

             
Votes For   %   Votes Against   %
34,956,863   94.74   1,940,459   5.26
             

ABOUT EXTENDICARE

Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 118 operated senior care and living centres (64 owned/54 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors' population in Canada. Our qualified and highly trained workforce of 23,400 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.

For further information, contact: Jillian Fountain Corporate Secretary Phone: (905) 470-5534 Fax: (905) 470-4003 Email: jfountain@extendicare.com Visit Extendicare's Website at www.extendicare.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 10

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 111

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 49

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 0

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 75

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 162

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles